ArticleCureus2021
Clinical Wide-Field Retinal Image Deep Learning Classification of Exudative and Non-Exudative Age-Related Macular Degeneration.
Article in Cureus, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Performance of Deep Learning in Classifying Age-Related Macular Degeneration From Images: Systematic Review and Meta-Analysis.Journal of medical Internet research · 2026Pooled it
- Artificial intelligence for diagnosing exudative age-related macular degeneration.The Cochrane database of systematic reviews · 2024Pooled it
- External Validation of Deep Learning Models for Classifying Etiology of Retinal Hemorrhage Using Diverse Fundus Photography Datasets.Bioengineering (Basel, Switzerland) · 2024Article
- Lesion classification and diabetic retinopathy grading by integrating softmax and pooling operators into vision transformer.Frontiers in public health · 2024Article
- Applications of deep learning for detecting ophthalmic diseases with ultrawide-field fundus images.International journal of ophthalmology · 2024Review
- An Analysis of the Usage of Retinal Imaging Technology in the Detection of Age-Related Macular Degeneration.Cureus · 2023Review
- Review
- Research progress on diagnosing retinal vascular diseases based on artificial intelligence and fundus images.Frontiers in cell and developmental biology · 2023Review
- Multi-label classification of retinal disease via a novel vision transformer model.Frontiers in neuroscience · 2023Article
- Artificial intelligence-based strategies to identify patient populations and advance analysis in age-related macular degeneration clinical trials.Experimental eye research · 2022Article
- Review
- Artificial intelligence in age-related macular degeneration: Advancing diagnosis, prognosis, and treatment.Survey of ophthalmologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAge-related macular degeneration (AMD) is a disease that currently affects approximately 196 million individuals and is projected to affect 288 million in 2040. As a result, better and earlier detection methods for this disease are needed in an effort to provide a higher quality of care. One way to achieve this is through the utilization of machine learning. A deep neural network, specifically a convoluted neural network (CNN) can be trained to differentiate between different types of AMD images given the proper training data.
methodsIn this study, a CNN was trained on 420 Optos wide-field retinal images for 70 epochs in order to classify between exudative and non-exudative AMD. These images were obtained and labeled by ophthalmologists from the Martel Eye Clinic in Rancho Cordova, CA. Results: After completing the study, a model was created with 88% accuracy. Both the training and validation loss started above 1 and ended below 0.2. Despite only analyzing a single image at a time, the model was still able to accurately identify if the individual had AMD in both eyes or one eye only. The model had the most trouble with bilateral non-exudative AMD. Overall the model was fairly accurate in the other categories. It was noted that the neural network was able to further differentiate from a single image if the disease is present in left, right, or both eyes. This is a point of contention for further investigation as it is impossible for the artificial intelligence (AI) to extrapolate the condition of both eyes from only one image.
conclusionThis research fostered the development of a CNN that was able to differentiate between exudative and non-exudative AMD. As well as determine if the disease is present in the right, left, or both eyes with a relatively high degree of accuracy. The model was trained on clinical data and can theoretically be used to classify other clinical images it has never encountered before.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.